Hongsheng N. Li
1838 Guangzhou North Road
Guangzhou, 510515, China
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Correction to: Photobiomodulation therapy moderates cancer cachexia‑associated muscle wasting through activating PI3K/AKT/FoxO3a pathway.
Journal: Apoptosis : an international journal on programmed cell death
Published: September 04, 2026
Bireociclib Plus Fulvestrant in Advanced Breast Cancer After Endocrine Progression: The BRIGHT-2 Phase 3 Randomized Clinical Trial.
Journal: JAMA oncology
Published: March 19, 2026
Retraction Note to: KLF5 regulated lncRNA RP1 promotes the growth and metastasis of breast cancer via repressing p27kip1 translation.
Journal: Cell death & disease
Published: April 08, 2025
Ferroptosis in cancer: revealing the multifaceted functions of mitochondria.
Journal: Cellular and molecular life sciences : CMLS
Published: March 09, 2025
Efbemalenograstim Alfa, an Fc Fusion Protein, Long‑Acting Granulocyte Colony-Stimulating Factor for Reducing the Risk of Chemotherapy-Induced Neutropenia: Results of a Phase II Randomized, Multicenter, Open‑Label Trial.
Journal: Clinical drug investigation
Published: December 24, 2024
Bireociclib plus fulvestrant for HR+/HER2- advanced female breast cancer progressed on or after endocrine therapy: phase 3 BRIGHT-2 study interim analysis.
Journal: Nature communications
Published: October 11, 2024
Granular cell astrocytomas/glioblastoma: report of a case
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: September 04, 2024
Segmentation and Vascular Vectorization for Coronary Artery by Geometry-Based Cascaded Neural Network.
Journal: IEEE transactions on medical imaging
Published: July 30, 2024
Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort.
Journal: Nature communications
Published: July 12, 2024
Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating PI3K/AKT/FoxO3a pathway.
Journal: Apoptosis : an international journal on programmed cell death
Published: February 18, 2024
QL1209 (pertuzumab biosimilar) versus reference pertuzumab plus trastuzumab and docetaxel in neoadjuvant treatment for HER2-positive, ER/PR-negative, early or locally advanced breast cancer: A multicenter, randomized, double-blinded, parallel-controlled, phase III equivalence trial.
Journal: British journal of cancer
Published: February 01, 2024
Last Updated: 09/26/2026